Condition
Vascular Cognitive Impairment no Dementia
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (2)
Trial Status
Completed2
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06898931Not ApplicableNot Yet RecruitingPrimary
Language Intervention Training for Cognitive Protection in High-risk Cardio-Cerebrovascular Elderly Population
NCT03306979Phase 2CompletedPrimary
Memory and Antioxidants in Vascular Impairment Trial
NCT02640716Not ApplicableCompletedPrimary
Cog-VACCINE: Cognitive Training in Patients With Vascular Cognitive Impairment, no Dementia
NCT02993367Phase 2UnknownPrimary
The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND
Showing all 4 trials